Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals recalls specific lots of Lidocaine Ointment USP 5% due to failed content uniformity specifications. Check your lot numbers.
Use caution until it’s fixed
Failed Content Uniformity Specifications
What happened, in plain English
Preferred Pharmaceuticals, Inc. is recalling Lidocaine Ointment USP, 5% (a generic for Xylocaine) packaged in 50 g jars. The recall is necessary because the product failed content uniformity specifications. This means the amount of active ingredient may not be consistent throughout the jar. Read more at govinfonow.com/recall/1622870-preferred-pharmaceuticals-inc-recalls-lidocaine-ointment-usp-5-generic-for.
Source Summary by GovInfoNow · govinfonow.com/recall/1622870-preferred-pharmaceuticals-inc-recalls-lidocaine-ointment-usp-5-generic-for · Published October 21, 2026 · Updated October 21, 2026 · FDA enforcement record: FDA #D-0013-2027
Cite this page
“Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues.” GovInfoNow, updated October 21, 2026. https://govinfonow.com/recall/1622870-preferred-pharmaceuticals-inc-recalls-lidocaine-ointment-usp-5-generic-for. Based on FDA recall #D-0013-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0013-2027%22&limit=1).
Why it’s dangerous
The ointment failed content uniformity specifications, which can result in uneven distribution of the active ingredient (lidocaine). This inconsistency means users might receive too little or too much medication per application, potentially affecting treatment efficacy or safety.
Who’s affected
Consumers who purchased this prescription-only ointment nationwide in the USA are affected. Patients relying on this specific medication for pain relief may receive a product with inconsistent dosing.
How to tell if you have this one
Look for Lidocaine Ointment USP, 5% in a 50 g jar with NDC 68788-7865-05. Check the lot numbers on the packaging: F1925G, E0925T, D3025M, or D0825D. All affected lots have an expiry date of 4/30/2027.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Check Your Lot Numbers
Verify if your jar has one of the recalled lot numbers: F1925G, E0925T, D3025M, or D0825D.
Contact Your Pharmacist
Since this is an Rx-only product, consult your pharmacist or healthcare provider for guidance on replacement or return.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 16 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Preferred Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0013-2027 (September 28, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0013-2027 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 21, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.